Aspen Aerogels (ASPN) director awarded RSUs and stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Aspen Aerogels director James E. Sweetnam received new equity awards. He was granted 10,370 Restricted Stock Units as part of his annual compensation for service as a non-employee director. Each RSU converts into one share of common stock upon vesting in 2027.
He also received stock options for 8,706 shares of common stock at an exercise price of $5.40 per share, expiring on May 13, 2036. Following these awards, he holds 36,321 shares of common stock, including 10,370 RSUs.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
SWEETNAM JAMES E
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 8,706 | $0.00 | -- |
| Grant/Award | Common Stock | 10,370 | $0.00 | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 8,706 shares (Direct, null);
Common Stock — 36,321 shares (Direct, null)
Footnotes (1)
- The reporting person was granted Restricted Stock Units ("RSUs") representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs will vest on the earlier of (a) May 13, 2027, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2027. Represents 25,951 shares of Common Stock and 10,370 RSUs. The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) May 13, 2027, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2027.
Key Figures
RSUs granted: 10,370 RSUs
Options granted: 8,706 options
Option exercise price: $5.40 per share
+3 more
6 metrics
RSUs granted
10,370 RSUs
Annual equity grant for non-employee director on May 13, 2026
Options granted
8,706 options
Stock Options (Right to Buy) granted on May 13, 2026
Option exercise price
<money>$5.40</money> per share
Exercise price for 8,706 stock options
Option expiration
<date>May 13, 2036</date>
Expiration date of granted stock options
Shares after transaction
36,321 shares
Common stock holdings following reported grants
Common shares vs RSUs
25,951 shares + 10,370 RSUs
Breakdown of 36,321 common stock-related holdings
Key Terms
Restricted Stock Units ("RSUs"), Non-Employee Director Compensation Policy, Stock Options (Right to Buy), exercise price, +1 more
5 terms
Restricted Stock Units ("RSUs") financial
"The reporting person was granted Restricted Stock Units ("RSUs") representing a portion of the annual grant of equity"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Non-Employee Director Compensation Policy financial
"for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy"
Stock Options (Right to Buy) financial
"The reporting person was granted options representing the remaining portion of the annual grant of equity"
exercise price financial
"conversion_or_exercise_price": "5.4000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
annual grant of equity financial
"representing a portion of the annual grant of equity for service as a non-employee director"
FAQ
What insider transaction did ASPN director James E. Sweetnam report?
James E. Sweetnam reported receiving equity awards, not open-market trades. He was granted 10,370 Restricted Stock Units and 8,706 stock options as part of his annual compensation for serving as a non-employee director of Aspen Aerogels.
How many Aspen Aerogels (ASPN) RSUs did James E. Sweetnam receive?
He received 10,370 Restricted Stock Units. Each RSU represents the right to receive one share of Aspen Aerogels common stock upon vesting, which is scheduled for the earlier of May 13, 2027, or the day before the company’s 2027 annual stockholder meeting.
What are the terms of the stock options granted to ASPN director Sweetnam?
He received options on 8,706 shares of Aspen Aerogels common stock with an exercise price of $5.40 per share. These options vest on the same 2027 schedule as the RSUs and expire on May 13, 2036, giving long-term exercise flexibility.
When will James E. Sweetnam’s Aspen Aerogels RSUs and options vest?
Both the 10,370 RSUs and the 8,706 stock options will vest on the earlier of May 13, 2027, or the day prior to Aspen Aerogels’ annual meeting of stockholders to be held in 2027, aligning vesting with the company’s director compensation cycle.
Is the ASPN Form 4 for James E. Sweetnam a stock purchase or sale?
The Form 4 shows compensation-related acquisitions, not market trades. The transactions are coded as grants of RSUs and stock options, meaning they are awards for board service rather than open-market buying or selling of Aspen Aerogels shares.